Between 2021 and 2023, 47% of Americans had hypertension, based on NHANES data. During those years, 79% of people with ...

A large U.S. clinical trial found that while multivitamins aren’t a universal fix, they may offer subtle blood pressure ...

Overcoming clinical inertia around starting and intensifying antihypertensive drugs is key, a researcher says.

FLORENCE, Italy — During the 2025 European Congress of Internal Medicine, held from March 5 to 8, the scientific program featured a special session in collaboration with the European Society of ...

In this Q&A, Mineralys CEO Jon Congleton discusses how targeting aldosterone could reshape hypertension treatment. Aldosterone synthase inhibitors (ASIs) are drawing a lot of attention. What first ...

Not all subtypes carry the same long-term cardiovascular risks, South Korean analysis show ...

(Beyond Pesticides, June 4, 2025) A new study published in Environmental Chemistry and Ecotoxicology finds that “higher pesticide exposure was significantly associated with elevated blood pressure and ...

A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary ...

Pediatric hypertension is linked to long-term cardiovascular risks, necessitating accurate diagnosis through repeated blood pressure measurements. Global prevalence of sustained hypertension in ...

A community-based remote patient monitoring (RPM) program was associated with significant reduction in blood pressure in Medicare patients with stage 2 hypertension, highlighting the potential ...